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Human T cell Lymphotropic Virus Type I (HTLV-I) associated infective dermatitis, first 
described by Sweet in Jamaican children, is a pattern of eczema characterized by 
exudation, crusting around the nostrils, ears and scalp with eventual appearance of a 
generalized fine papular rash. More recently LeGranade and co-workers have proposed 
major and minor criteria in establishing the diagnosis of HTLV-I associated infective 
dermatitis (HAID). 
HTLV-I has been aetiologically linked to Adult T cell leukaemia/lymphoma (ATLL) and 
tropical spastic paraparesis (TSP). HAID is not only a marker of childhood infection with 
HTLV-I but may be a harbinger of more serious HTLV-I associated diseases later on in 
life such as ATLL or TSP. The pathogenesis of HAID is poorly understood so are the 
histopathological features of this entity. The effects of co-infection with human 
immunodeficiency virus- 1 (HIV-1) are inconclusive. 
HAID is described in Sub Saharan Africa, Senegal but no data is published on this entity 
in Southern Africa, characterizing the clinical, laboratory features and the histopathology 
of this entity. 
Aims and Objectives 
1) To describe the clinical and histological features of HTLV-I associated infective 
dermatitis in KZN, South Africa 
2) To determine the virological characteristics of HTLV-I in KZN, South Africa 
3) To assess for HTLV-I / HIV co-infection 
Methods 
This was a prospective study of all patients with HAID who presented to King Edward 
VIII hospital (KEH), outpatient department over a period of 42 months. These were 
patients who fulfilled the clinical criteria of HAID. Enrolled patients were subjected to a 
confirmatory HTLV-I serology testing. Demographic data was obtained from all HTLV-I 
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seropositive patients. Their clinical examination included dermatological, neurological 
and pathological examination. A blood count, immunoglobulin levels, serum protein 
electrophoresis measuring albumin levels and globulin fractions were measured. For 
bacteriological assessment skin swabs were taken from the affected sites with stool 
samples examined for parasites, ova and cysts. 
The HIV-1 status together with HIV-1 viral load were determined on those enrolled. The 
CD4 count, CD8 counts and CD4/CD8 ratio were also calculated. Skin biopsies were 
taken for histological examination. PCR for HTLV subtyping was performed on a subset 
of the cohort. 
Results 
Demography 
Of the 60 patients recruited, 33 fulfilled criteria for HAID. The majority of patients fell 
between age categories of 6 to lOyears. The male to female ratio was 1:1. There were 
more females in the adult group than there were within the childhood group. All of the 
patients in our cohort were African. 
Clinical features 
The lesions were erythematous, scaly, exudative, and crusted in all cases. The distribution 
of lesions was as follows: scalp (77.4%), retroauricular areas (71%), the axilla (65%) and 
paranasal areas (58%) were the sites more commonly affected. Nasal crusting was not a 
significant feature in this series. 
Bacteriology 
Culture was positive for Staphylococcus aureus (S. aureus) in 90%, with streptococcal 
group of organisms found in 68% of the skin swabs taken from the lesional skin. 
Haematological 
Our patients were mildly anaemic as has been shown in previous studies. They had a 
mean Hb of 11.5g/dl. In 12 of the 14 patients tested, the erythrocyte sedimentation rate 
(ESR) was elevated. Serum protein electrophoresis and levels of Immunoglobulin A, G 
and M were raised. The mean CD4 count in the entire group was elevated at 1730 
cells/fil, CD8 was 1299 cells/ul 
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Histopathology 
The major histological findings were as follows: 38% demonstrated a superficial and 
deep perivascular inflammatory infiltrate, 28% had a superficial and deep perivascular 
inflammatory infiltrate together with a lichenoid dermatitis, 12.9% had features of 
superficial and deep inflammatory infiltrate with an interface dermatitis, 6.4% revealed 
features of seborrhoeic dermatitis. 
Genotyping 
Our patients were infected with the strains belonging to the Cosmopolitan, A Subtype 
(HTLV-Ia). 
Complications 
Complications were low in this series with the commonest being scabies in 6(18.1%), 
corneal opacities in 3(8.6%), 2(6 %) with HAM/TSP. No parasitic worm infestations 
were isolated. 
HIV/HTLV-I co-infection 
Of the 33 patients, 9 (30 %) were co-infected with HIV. The mean viral load in this group 
was 52 000 copies/ml. Their mean CD4 count was also elevated at 1505cells/^il with a 
CD8 of 1704 cells/Mi and a CD4/CD8 ratio of 1.15. 
Discussion 
Thirty three of the 60 patients enrolled met the diagnosis for HAID according to the 
established criteria. The mean age in this series was 17 years (range: 8 months-46 years) 
however; almost a third (30.3%) were children under 12 years, reinforcing the entity as a 
childhood infective condition. 
There was an equal male female distribution in the childhood group and a female 
predominance in the adult group. 
Clinically patients presented with infected erythematous, scaly lesions mainly on the 
scalp, neck and post- auricular area. The clinical features were in keeping with other 
series worldwide. The complication rate was low in our cohort. 
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S. aureus was the predominant organism in both anterior nares and lesional skin. The 
most common histological pattern was superficial and deep perivascular inflammatory 
infiltrate. The subtype in our series was the Cosmopolitan Subtype A (HTLV-Ia) as 
opposed to subtype B in Japan. We share with Brazil a common subtype. 
A subset of our patients (30%) was co-infected with HIV. The CD4 cell count in this 
subgroup was lower than the entire group but this was not statistically significant. The 
histological patterns found in this subgroup infected with HIV were similar to the rest of 
the group except for a more intense eosinophilic infiltrate in these skin biopsy specimens. 
Conclusion 
HTLV-I associated infective dermatitis is distinct entity which affects the African 
population of KwaZulu Natal, South Africa. It is predominantly a disease of childhood 
with an equal female to male ratio in children. The clinical features are an exudative, 
erythematous scaly rash most commonly found involving the scalp, axillae, paranasal and 
retroauricular areas. HTLV-I positivity is essential for the diagnosis; the Cosmopolitan 
Subtype A is commonest in South Africa. The commonest histological pattern is a 




INTRODUCTION AND LITERATURE REVIEW 
Human T cell lymphotropic virus type I (HTLV-I) associated infective dermatitis is a 
chronic and severe form of childhood dermatitis characterized by an exudative, infective 
dermatitis involving mainly the scalp, neck and ears. Other symptoms include a 
generalized papular rash, nasal discharge and crusting of the nostrils. The majority of 
described patients with this condition originate from Jamaica. 
The disease has also been reported in several HTLV-I endemic populations including 
Japan, Trinidad, Brazil and Columbia. Diagnosis is based on specific clinical and 
laboratory criteria, Table 1. The average onset is 2 years and 60% of patients are female. 
The incidence and prevalence are undefined, as is the pathogenesis. The skin 
manifestation becomes less severe with age.2 Long-term clinical studies have 
demonstrated that the rash is often followed by the development of HAM/TSP or ATLL.3 
Table 1. Clinical criteria of HAW4 
MAJOR 
1. Eczema of scalp, axillae and groin external ear and retro-auricular areas, eyelid 
margins, paranasal skin and/or neck 
2. Chronic watery nasal discharge without other signs of rhinitis and/or crusting of the 
anterior nares 
3. Chronic relapsing dermatitis with prompt response to appropriate therapy but prompt 
recurrence on withdrawal of use of antibiotic 
4. Usual onset in early childhood 
5. Human T cell lymphotropic virus type 1 antibody seropositivity 
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Table 1: Clinical Criteria of HAW4 (Ctd) 
MINOR 
1. Positive cultures for Staphylococcal aureus and/or Beta-haemolytic streptococci from 
the skin or anterior nares 
2. Generalized fine papular rash (in most severe cases) 
3. Generalized lymphadenopathy with dermatopathic lymphadenitis 
4. Anaemia 
5. Elevated erythrocyte sedimentation rate 
6. Hyperimmunoglobulinaemia (IgD and IgE) 
7. Elevated CD4 count, CD8 count, and CD4/CD8 ratio 
* Of the major criteria, 4 are required for the diagnosis with mandatory inclusion of 1, 2 and 5; to fulfil 
criteria 1, involvement of at least 2 sites are required. 
1.1 Background 
Recognition of this condition dates back to 1966 when RD Sweet brought the world's 
attention to a unique pattern of eczema in a group of children and adults that seemed to 
vary from the patterns seen in Europeans.5 He recognized that 17 of 28 patients who had 
been diagnosed with eczema were Jamaican. He noted that this peculiar type of eczema 
started at the age of 2 years. The lesions were infected from the time of onset and were 
located on nostrils, ears and spread to the rest of the face, the scalp and around the neck. 
He documented that some of these children developed a generalized fine papular eruption 
and that some patients came from the same family.5 He observed that the eruption cleared 
rapidly when treated with an antibiotic and steroid therapy and that the condition tended 
to relapse when these patients returned home after discharge on withdrawal of antibiotics. 
Recognising that this pattern defied the tidy classification of eczema he was accustomed 
to, he named it "A pattern of eczema in Jamaica".5 
The following year Margaret Walshe documented a study of 40 Jamaican children, 25 of 
whom suffered from the condition which had been described as "infective dermatitis" by 
Sweet.6 She amplified Sweet's original description, established criteria for diagnosis and 
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documented bacteriological findings. She also documented a high incidence of carriage 
of staphylococci or beta haemolytic streptococci or both in the noses or the skins of the 
patients with infective dermatitis than in those with other dermatoses. She also postulated 
that these children might be immunosuppressed and tentatively suggested malnutrition as 
the possible cause for the immunosuppression. 
It was 10 years after the discovery of HTLV-I7 that the first link of this early life infection 
with HTLV-I was documented. Le Granade and co-workers studied 147 consecutive 
patients between the ages 2 and 17 years over a period of one year, 14 of whom met the 
clinical definition of infective dermatitis. Each of these 14 children from Jamaica 
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underwent testing for HTLV-I and all 14 were positive for antibodies to HTLV-I. 
This relationship was later confirmed in a much larger number of patients where 50 
infective dermatitis patients were compared with 35 atopic dermatitis patients.4 In this 
case controlled study all 50 patients with infective dermatitis had results seropositive for 
HTLV-I. Only 5 of the 35 patients with atopic dermatitis were seropositive for HTLV-I. 
The results were negative for HIV-1 for all patients in the study, suggesting an aetiologic 
role for HTLV-I in infective dermatitis. In both groups, microbiologic studies showed 
frequent colonization with S. aureus or BHS. On comparing the blood count findings 
between the two groups, patients with infective dermatitis were anaemic, had higher 
WCC and had an elevated ESR than patients with AD. They also had a significantly 
higher incidence of abnormal serum proteins and dermatopathic lymphadenopathy.4 Le 
Granade and co-workers in this study proposed a new designation of infective dermatitis 
("HTLV-I associated infective dermatitis") and the major and minor criteria for the 
diagnosis, Table!. 
Since the original report in 1990, cases of infective dermatitis have been described from 
Trinidad, Tobago, Japan, and Columbia, Barbados and among Haitian immigrant children 
in Miami but the numbers so far have been small. In Trinidad and Tobago, 15 people 
were described with chronic relapsing infective dermatitis all of whom were seropositive 
for antibody to HTLV-I.9 
17 
In Africa, the only published study was the one conducted in Senegal where 5 cases of 
this condition was reported.10 
More recently a group of investigators documented the frequency of HAID in Salvador, 
Brazil confirming 23 cases in patients attending a dermatology outpatient clinic of the 
Federal University of Bahia. In this study all 23 patients demonstrated clinical features of 
HAID and were positive for HTLV-I. These children were followed up for a median of 3 
years and 5 developed HAM/TSP.11 
There have been fewer than 10 original papers documenting the entity of HAID 
worldwide. These have mainly come from areas endemic with HTLV-I. There has been 
one study from Africa, none from Southern Africa. Table 2 emphasises the paucity of the 
work done so far on this entity. 
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1.2 Virological Characteristics 
HTLV-I is an enveloped double stranded RNA, type C virus (Retroviridae family, 
subfamily oncovirus).3 Mature virions are 110 -140 nm in diameter, characterized by a 
spherical, centrally located nucleiod enveloped by a glycoprotein membrane with short 
spikes. 
The HTLV-I envelope is a lipid bilayer in which the smaller transmembrane viral protein 
(gp21) and the larger outer protein (gp46) are anchored. 
The core consists of a diploid RNA genome of high molecular weight (approximately 
9056 bp long) with structural features common to all retroviruses, namely the genes 
for group specific antigen (gag), reverse transcriptase (pol) and envelope protein 
(env), and flanked by long terminal repeat (LTR) sequences on either end, (Figure 
Dn 
The LTR comprises three distinct domains, U3, R and U5, in a 5' to 3' direction. The 
length of the repeat I sequence (228bp) of the LTR region is no longer than in the other 
retroviruses. HTLV-I also contains unique regulatory genes encoding for transactivating 
proteins (tax and rex) enveloped between the 3' untranslated end of the provirus and the 
env gene. The tax gene stimulates transcription of all genes from the 5' LTR sequences. 
The rex gene is a positive post-transcriptional regulator for the gag and env expression 
and is also a negative regulator capable of inhibiting expression and replication of HTLV-
I in vivo.12 
Transmission of HTLV-I is by cell-cell contact. The receptor(s) for entry of HTLV-I into 
the host's cell are unknown. More recently, studies have been reporting GLUT as the 
likely receptor for entry of HTLV-I into the cell.1 As a provirus within the infected cell, 
HTLV-I integrates itself into the host genome. Inside the cell, it synthesizes copies of 
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DNA by reverse transcriptase. Laboratory studies have shown that T cells are then 
transformed and immortalized. Unlike other type C transforming viruses, HTLV-I has not 
been found to possess cell derived oncogenes. 
[ | h « rex — r $ ^ g 1 
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Figure 1: A schematic map of the HTLV-I genome 
1.3 Epidemiology 
Infection with HTLV-I is a global epidemic affecting 10-20 million people 
worldwide.2 HTLV-I infection, is particularly endemic in southern Japan, but foci of 
infection are found in geographical clusters, the Caribbean, parts of Africa, the Middle 
East, South America, the Pacific Malanesian Islands, and Papua New Guinea. In USA 
and Europe HTLV-I infection is found in the carriers among immigrants from endemic 
areas.3 The virus is endemic in KZN.15 
1.3.1 Seroprevalence 
There are very few population based studies conducted on the epidemiology of HTLV-I 
infection. In areas where the studies were conducted, it was shown that HTLV-I 
seroprevalence ranges from 3-6% in Trinidad, Jamaica, and other Caribbean Islands to 
30% in rural Miyazaki, southern Japan.3 USA and Europe has the lowest seroprevalence 
rate, found to be less than 1% among low risk populations.3 Population studies have 
shown that HTLV-I seroprevalence increases with age and is twice as high in females.3 
There is paucity of epidemiological evidence for HTLV-I in Africa. A few population 
studies conducted in parts of Africa have indicated an overall seroprevalence of 4%. This 
can be broken down into 1-15% prevalence in Zaire, 0.9% in Ghanaian refugees in 
20 
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Belguim and 0.2% in pregnant women in South Africa. Small studies conducted in 
South Africa (KZN) have shown an HTLV-I seroprevalence of 0.5-3.3% in different 
ethnic and geographical areas.15 
HAID incidence and prevalence remains unknown. The incidence rates of HAID in 
countries where it has been reported have not been published. However Trinidad's rates 
of ATLL and HAM/TSP are similar to Jamaica, whereas Japan has similar rates of ATLL 
but lower rates of HAM/TSP (0.4/100 000). Incidence rates for HTLV-I associated 
diseases in Columbia and Brazil have not been reported. However, the prevalence of 
HAM/TSP is known to be high (100/100 000 population) in Tumaco, Columbia.16 
Reports of HTLV-I positive ATLL in Africans remain scanty, probably because 
laboratory facilities and pathologists are scarce.17 
1.4 Geographical Subtypes 
Six different genetic subtypes of HTLV-I have been proposed based on phylogenetic 
analyses, summarised in Table 3: a - or Cosmopolitan which is distributed worldwide;18 
b - from Central Africa;19 c - a highly divergent Melanesian strain from Papua Guinea 
and Australia;20 d - isolated from Central African Republic (CAR) pygmies, and from 
9 1 99 
two patients in Cameroon and Gabon; ' e - isolated in a single sample from an Efe 
pygmy in the Democratic Republic of Congo (DRC); and subtype f - detected in an 
individual from Gabon.23 The most widespread and best studied subtype, Cosmopolitan, 
is further divided into five subgroups based on geographical distribution : 
Transcontinental (A), Japanese (B), West African / Caribbean (C), North African 
(D) and Black Peruvian (E).18'24'25'26 Previous studies have reported that HTLV-I strains 
from KwaZulu Natal, South Africa belong to the A subgroup of the Cosmopolitan 
(HTLV-Ia subtype).27 
21 













West Africa/Caribbean I 
North Africa (D) 





Papua New Guinea + Australia 
Central African Republic 
Democratic Republic of Congo 
Gabon 
1.5 Clinical Features of HAID 
HAID is a chronic and recurrent eczema occurring during childhood and adolescence. It 
is distinctive, often beginning with a rhinitis labelled by the mother as a "cold".28 This is 
followed by an oozing, weeping eruption on the scalp, ears, neck, axillae, umbilicus, 
groin, perineum and natal cleft often associated with a blepharo-conjunctivitis. The full 
clinical picture is that of a severe exudative dermatitis with crusting of the scalp, neck, 
axillae, groin, external ear, and retro-auricular areas; watery nasal discharge, and/or 
crusting of the anterior nares; generalized fine papular rash, culture from the anterior 
nares or skin showing Staphylococcus aureus (S.aureus) and/or beta-haemolytic 
streptococcus (BHS); and prompt response to appropriate antibiotic therapy and equally 
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rapid relapse, if such antibiotics are withdrawn. Figures 2a and 2b show the typical 
clinical appearance of a patient during a relapse. 
2a) 2b) 
Figure 2a and 2b: Clinical picture of a relapse in a patient with HAID 
1.6 Pathogenesis 
The pathogenesis of HAID is poorly understood. It is the resistance to treatment, the 
frequent exacerbations and the infections with bacteria that are usually non-virulent in 
those affected which raises the possibility that infective dermatitis may be a disorder of 
immunosuppression.7 
Data demonstrate evidence of altered immune function with hyperactivity of both 
humoral and cellular immune systems but the precise immunological abnormality 
remains to be elucidated. 
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The question of why some children infected with HTLV-I develop HAID while others are 
asymptomatic remains unanswered. This observation suggests the role of other factors in 
the development of HAID, the possibilities being environment or lifestyle related to 
socioeconomic status since patients are usually from the lower socioeconomic sectors of 
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the population, as well as the immuno-genetic background. 
Postulated so far is that HTLV-I alters the immune system of affected patients, rendering 
them incapable of overcoming infection with Staphylococcus and BHS resulting in 
chronic bacterial infections.28 
The fact that immune suppression played a role in the pathogenesis was suggested as 
early as in the cases described by Walshe. She postulated that children with this disease 
were immunosuppressed and suggested malnutrition as a possible cause of the 
immunosuppression. However, she herself noted that only a minority were in fact 
obviously malnourished. 
HTLV-I is tropic for cells with a CD4 phenotype and infected cells can express type 
MHC haplotypes (HLA-DR) as well as CD25.30 
Recent data suggest HTLV-I infection might be the cause of the immune dysfunction 
among HAID patients. 29 by inducing an increased expression of interleukin -2 (IL-2) 
receptors in HTLV-I infected cells. This may result in preferential binding of soluble IL-2 
o 
with consequent reduction in the effective concentration of IL-2. In addition, a change in 
the functional phenotype induced by HTLV-I creates a deficiency in cell-cell interaction 
resulting in immune dysregulation. Genes of several proinflammatory cytokines such as 
interleukin 1, interleukin 6 and tumour necrosis factor a, are transactivated by the viral 
tax protein. It is postulated that the secretion of such cytokines by infected cells amplifies 
and/or maintains the inflammatory reaction in the skin and that this may be responsible 
for the recalcitrant nature of HAID.31 
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Genetic studies done in a single family, a mother and her two sons, indicate that there is a 
possible genetic predisposition contributing to the development of HAID. The results in 
this study showed the index case and her two sons to be the only family members to share 
a common haplotype namely DRB1*DQB1* (1101- 0301). This is one of the haplotypes 
associated with HAM/TSP among Japanese patients which correlates with high immune 
response and high antibody titers to HTLV-I. It is postulated that haplotype 
DRB1*DQB1* (1101-0301) may determine susceptibility to HMD.29 These observations 
point to the similarities of genetic background between patients with HAID and those 
with HAM/TSP. This therefore suggests that susceptibility to these diseases observed in 
patients with HAID could marked by these HLA haplotypes.16 
Whether HTLV-I is involved in the pathogenesis of the skin lesions or is present in the 
skin because inflammatory cells containing virus migrated to the lesion remains a 
question. The skin cells in addition to lymphocytes may be infected by the virus.32 
1.7 Pathology 
The histopathological features characterizing this entity have yet to be determined. There 
is a paucity of literature on this subject. The investigators who searched for specific 
features of this entity found that pathological aspects were similar to other types of 
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chronic eczema. 
More recently, 19 patients with HAID were studied histologically and 
immunohistologically using the following antibodies: anti-CD3, CD45RO, CD20, 
CD79a, CD4, CD8, CD57, TIA-1, granzyme-B and perforin A.33 Chronic dermatitis 
features similar to that of seborrhoeic dermatitis was observed in 15 of these patients, 
whereas architecturally aspects mimicking mycoses fungoides (MF) were observed in the 
remaining 4 patients. The specific features that characterize HAID remain to be 
answered. It was with this background above that we set out to investigate histological 
features of HAID. 
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1.8 Disease Transmission 
HTLV-I infection is blood borne and can be transmitted by blood-blood contact as well 
as by sexual contact. Transfusion is the most efficient mode of virus transmission. It has 
been shown that the probability of seroconversion in a recipient of contaminated blood 
can be as high as 40-60% with the median time to seroconversion of 51 days. Sexual 
intercourse is recognized as an important factor for HTLV-I transmission.34 Sexual 
intercourse is recognized as an important factor for HTLV-I transmission.34 HTLV-I has 
been detected in the semen and cervical secretion of infected persons. Most HTLV-I 
infections are attributable to transmission from mother to child with the mother's milk 
being a major risk factor of infection.35 The probability of mother to infant transmission 
is 18-30%.3 Maternal risk factors include higher HTLV-I antibody titre, prolonged 
ruptured membranes during delivery and low socioeconomic status. Breastfeeding for 
more than 6 months has been associated with transmission which has led to the 
hypothesis that shortening the duration of breastfeeding may reduce the risk of HTLV-I 
transmission. However infection still occurs in about 3% of patients who are not 
breastfed.3 
1.9 Modes of Detection 
HTLV-I infection can be easily detected by screening blood for specific antibodies, using 
enzyme-linked immunoassay (EIA or ELISA) techniques. Gelatin particle agglutination 
(GPA or PA), immunoflouresence (IF), radioimmunoprecipitation assays (RIPA) are 
other common serological screening used in the diagnosis. Samples that react repeatedly 
in anti-HTLV-I screening assays need to be retested in an immunoblot assay. Highly 
sensitive HTLV-1/2 immunoblot assays like the Line immunoassay (LIA) and Western 
blot (WB) are most commonly used.35 Advanced methods, such as the HTLV- specific 
polymerase chain reaction (PCR) tests in combination with T-cells culture may be of 
additional value since they are able to detect the viruses with increased sensitivity. 
Guidelines from the US Public Health Service, WHO and other international groups such 
as the HERN (HTLV European Research Network)36, recommend that newly identified 
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seropositive individuals have additional blood collected for repeat testing to eliminate 
possible technical errors, also to distinguish HTLV-I from HTLV-II. HTLV-II has 65% 
sequence homology to HTLV-I. HTLV-II infection is present predominantly amongst 
intravenous drug users (IVDU) and is usually a co-infection with HIV-I. It is difficult to 
distinguish the two from one another unless virus specific reagents are used. The 
distinction is important because HTLV-II is less pathogenic than HTLV-I. 
1.10 HTLV-I associated diseases 
HTLV-I was the first human retrovirus described as causing disease. It was first isolated 
from cell lines from patients with ATLL.37 Since then HTLV-I has been shown to be 
aetiologically associated with a number of diseases, Table 4. Of these ATLL, TSP/HAM 
and HAID are most widely researched. 
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1.10.1 Adult T cell leukaemia / lymphoma (ATLL) 
ATLL is a uniformly fatal T-cell malignancy. Among HTLV-I carriers, less than 5% of 
individuals develop ATLL. HTLV-I is an indolent virus. A long latency period between 
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infection and subsequent development of disease has been documented. ATLL occurs 
predominantly in the age range of 40-70 years with average age of onset being about 60 
years in Japan but only 40 in Jamaica, Trinidad and Brazil. This difference is 
unexplained.3 It is rapidly progressive, usually resistant to chemotherapy. Most patients 
die of this disease within a few months. It appears to be restricted to individuals with a 
lifelong infection.39 Combination chemotherapy has been used to treat ATLL, but long 
term survival has been very limited especially in the acute and lymphoma types. 
1.10.2 HTLV-I Associated Myelopathy / Tropical Spastic Paraparesis (HAM/TSP) 
A chronic disabling demyelinating neurological disorder characterized by slowly 
progressive spastic paraparesis and bladder disturbances.1 The disease commonly follows 
adult acquired infection by either sexual contact or through blood transfusion but may 
follow a childhood infection. Symptom progression seems to be more rapid in blood 
transfusion associated HAM/TSP than in the cases of mother to child transmission.2 The 
incubation period from infection to the onset of myelopathic symptoms is believed to 
range from months to decades. This is a progressively disabling disorder with studies 
showing that one-half of patients with this disease become wheel chair bound within 10 
years of acquiring it.17 There is no definite therapy for this condition.2 Secondary 
complications may lead to death after many years. 
1.10.3 HTLV-I Associated Uveitis 
This intraocular inflammatory disorder has been associated with a variety of infectious 
causes including tuberculosis, syphilis, cytomegalovirus, toxoplomosis or non-infections 
causes such as Behcet's, sarcoidosis and Vogt-Koyanagi-Harada syndrome(reviewed in 
). In about 40% of cases, a firm cause is not identified. It was a high number unexplained 
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cases of uveitis (idiopathic uveitis) in HTLV-I endemic areas that led to speculation that 
HTLV-I might be the cause. An association with HTLV-I was established when 35% of 
patients with idiopathic uveitis were found to be HTLV-I positive compared with 10% of 
uveitis cases where another cause has been identified. A patient with HTLV-I uveitis 
presents with a variety of clinical symptoms including blurred or foggy vision and acute, 
sudden onset of "floaters" (reviewed in ). Iritis, vitreous opacity, retinal vasculitis, 
retinal exudates and haemorrhages are all signs that may be found on ophthalmologic 
examination. PCR is used to establish clinical diagnosis through detection of proviral 
DNA in mononuclear cells in peripheral blood and vitreous humour. Topical and 
systemic corticosteroids may improve visual acuity (reviewed in ). 
1.11 Complications 
Long term HTLV-I infection may be entirely asymptomatic but clinical or subclinical 
consequences may affect various organ systems. Complications occur in 30-35% of 
patients. 
Asymptomatic carriers of HTLV-I have been reported to harbour various infections 
including strongyloidiasis, trypanosomiasis and leishmaniasis.8 Other complications 
include: scabies, corneal opacities, chronic bronchiectasis, regressing atypical 
histiocytosis, glomerulonephritis and lymphocytic interstitial pneumonia. ' Some 
patients with HAID where HTLV-I is endemic may go on and develop severe HTLV-I 
related illnesses such as TSP/HAM or ATLL." 
In addition to HAID, Strongyloides stercoralis (Ss) infection has been proposed as a 
cofactorof ATLL.40 
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1.12 Natural History 
The steps leading from virus infection to the development of the different HTLV-I 
associated conditions are partly understood.40 Some patients become carriers of the 
disease while others go on to develop HTLV-I related illnesses. 
Although HTLV-I infection is frequently asymptomatic, the risk of disease in long term 
infection has been under recognized yet it could have significant health implications. 
Early diagnosis of HTLV-I allows neurological and lymphoreticular symptoms to be 
taken into account in the clinical care of patients and makes it possible to provide 
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preventative counselling to reduce the likelihood of infection transmission. 
It is estimated that the cumulative lifetime risk of developing a life threatening or 
debilitating disease as a result of HTLV-I is approximately 5% increasing to 8-10% when 
the patient has other illnesses. 
Epidemiological data suggest that HAID is not only a marker for childhood HTLV-I 
infection but also a possible harbinger of more serious HTLV-I associated disorders later 
in life as there have been reports on occurrence of ATLL in patients 12-25 years after a 
diagnosis of HAID. 
A suggested postulate is that an exaggerated host response to the presence of HTLV-I, 
coupled with the virus's ability to immortalise T cell-clones predisposes them to 
malignant transformation due to accumulation of genomic mutations." Among HTLV-I 
carriers less than 5% of individuals develop ATLL or HAM/TSP and there is usually a 
long latency of decades between infection and subsequent development of disease with 
the exception of transfusion associated HAM/TSP which can develop several weeks to 
months following infection from contaminated blood components.3 
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1.13 Treatment 
Treatment of HAID is currently aimed at controlling infection with S. aureus and BHS by 
using appropriate antibiotic therapy. This measure alone keeps the dermatitis fairly well 
controlled and may require addition of mild topical steroids for full control. Prolonged 
use of antibiotics is recommended in the literature until puberty at which time the severity 
of the bacterial infection seems to lessen. Relapses always occur following the 
withdrawal of the drug treatment. A combination of artificial feeding, prophylactic 
immunoglobulin and perhaps antiretroviral therapy need to be investigated for possible 
use in the control of infection. Some investigators are also exploring the feasibility of an 
HTLV-I vaccine.3 
1.14 HIV / HTLV-I co-infection 
1.14.1 Historical Review 
A year after the discovery of HTLV-I, a cluster of patients with a novel disease of 
acquired cellular immunodeficiency, later known as the acquired immunodefiency 
syndrome (AIDS), was first described.17 In the following 2 years several groups isolated a 
retrovirus from patients with AIDS. This virus was called lymphadenopathy - associated 
virus (LAV), Human T cell lymphoma virus type III (HTLV-III) or Aids Related Virus 
(ARV). In 1986 these isolates were grouped under the name Human Immunodeficiency 
Virus (HIV). This later discovery of HIV has given rise to the massive interest in HIV 
and AIDS worldwide. 
1.14.2 Structural Differences 
Structural features are common to all retroviruses, (Figure 3). The core proteins of HIV 
and HTLV-I have similar molecular weights and are designated pi5, pl7 and p24 (p26 in 
HIV-II).17 Glycoprotein's 120 (gpl20) and 130 (gpl30) are major glycoproteins of HIV-I 
and HIV-II is respectively. In contrast to HIV, the size of the cleaved glycoprotein 
precursor of HTLV's gp68 is much smaller. The HIV virus encode additional proteins 
called virion infectivity factor (vif), transactivator (tat), a regulator protein of expression 
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of virion proteins (rev) and a negative factor (nef) which inhibit the replication of the 
HIV. In contrast, HTLV have a rex and tax which encode a p40 and p27/p21 molecule 
respectively which is not present within the HIV structure. The p40 augments viral RNA 
expression, while p27/p21 enhances the expression of viral genes.16 Despite the 
similarities, HIV is classified as belonging to the family of Lentivirinae as it is associated 
with slowly progressive inflammatory and degenerative disorders while HTLV belongs to 
the family Oncovirinae as these viruses are associated with malignancies.17 
•< rex 










Figure 3: A schematic map of HTLV-I/II genome in comparison with HIV genome 14 
Similar modes of transmission are observed with both retroviruses and are by three 
routes, namely, (1) intimate sexual contact, (2) perinatally (predominantly through 
breastfeeding and (3) parentrally (through blood transfusion or exposure to needles and 
syringes contaminated with blood). The risk of male infection is increased with 
concomitant penile ulcers and concurrent syphilis, which holds true for both retroviruses.3 
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Co-infection with HTLV-I is common in some populations infected with HIV, 
particularly from regions with high HIV prevalence, e.g. KZN in South Africa. Whether 
HTLV-I /II influences the outcome in patients with HIV remains to be known.4 
HIV positive patients co-infected with HTLV-I seem to have more severe 
immunosuppression than do the HTLV-I seronegatives.8 HTLV-I can increases HIV 
replication in vitro and several studies suggest that HTLV-I accelerates the progression of 
HIV and in turn progression to AIDS.43 Several other studies have suggested that HTLV-
I does not appear to affect HIV viral load, currently considered to be the best marker of 
HIV disease progression.4 
Several mechanisms have been proposed concerning HTLV-I and HIV co-infections (in 
vitro studies): CD4 lymphocytes infected with HTLV-I are immortalized via stimulation 
of IL-2 and its receptor. Translocation of the replicating factor, NFKB in the nucleus 
activates the T lymphocytes. The product of HTLV-I tax gene will also have a 
transactivating effect on the provirus HIV-LTR replication. Finally infection with HTLV-
I may facilitate HIV by inducing CD4, expression in non-expressing cells.44 
1.14.3 Local Experience 
The first cases of HAM/TSP in the Orange Free State were reported by van der Ryst and 
colleagues where 18% of HTLV-I positive patients with spastic myelopathy had 
HAM/TSP.45 Most work has been carried out by Bhigjee and colleagues in the 
Ngwelezana district in 1993; a 2.6% seroprevalence was found .15 A follow up study at 
Ubombo showed a seroprevalence rate of 3.33%.I2 This emphasized the fact HTLV-I is 
endemic in KZN. 
Previous studies have reported that HTLV-I strains from KZN, South Africa belong to 
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the A subgroup of the Cosmopolitan (HTLV-Ia) subtype. HTLV-I associated infective 
dermatitis from the southern part of Africa is not as well documented as it is in the 
Caribbean Islands. There has not been any study documenting this entity in patients 
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presenting with a typical rash neither has there been any characterizing the 




To document the clinicopathological and virological characteristics of HTLV-I associated 
infective dermatitis in KZN, South Africa. 
2.2. Objectives 
1. To describe the clinical and histological features of HTLV-I associated infective 
dermatitis in KZN, South Africa. 
2. To determine the virological characteristics of HTLV-I in KZN, South Africa. 
3. To assess for HTLV-I / HIV co-infection. 
2.3 Methods 
This was a prospective study carried out in the dermatology outpatient department of 
King Edward VIII Hospital, a major tertiary referral hospital in KZN, South Africa. The 
study was carried out over a 3 year period starting from January 2003 till December 
2005. This study commenced following ethics approval from the University of KZN's 
Biomedical Research Ethics Committee (HI81/03). 
All patients who presented with clinical features in keeping HTLV-I associated infective 
dermatitis were informed of the study and were invited to participate. Only those who 
gave informed consent were recruited. Patients with features of seborrhoeic dermatitis 
who were HTLV-I negative, were found to be HIV infected. We did not come across 
patients who had clinical features of HAID who were HTLV-I and HIV negative. They 
had features of HIV seborrhoeic dermatitis and were therefore an unsuitable comparison 
group for HAID. 
Those recruited were then subjected to confirmatory HTLV-I testing. Where possible, 
parents and siblings of the participants were also recruited. 
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The various components of the study were: 
2.3.1 Clinical examination (see appendix) 
2.3.2 Laboratory investigations 
2.3.3 Histological investigation 
2.3.4 PCR and sequencing 
2.3.1 Clinical examination 
Clinical assessments performed for all patients included a medical history, a general and 
a detailed dermatological assessment. The diagnosis of HTLV-I associated infective 
dermatitis was made according to previously established criteria. Ophthalmologic 
examination was performed on all patients who had visual complaints. All patients with 
signs of neurological abnormalities were sent to the neurology department for a detailed 
neurological evaluation. 
2.3.2 Laboratory investigation 
The following laboratory tests were performed for patients with suspected HAID: These 
have been summarised in Table 5, below. 









HTLV-I, HIV , HIV viral load 
Skin swabs, stool for culture 
CD4, CD8 counts, CD4/8 ratio 
Chest radiograph 
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Haematological analysis included complete blood count with differential white cell count 
(WCC) and measurement of erythrocyte sedimentation rate (ESR). Serum protein 
electrophoresis was used to measure albumin levels and globulin fractions. Measurement 
of serum levels of IgA, IgE, IgG, IgM. Skin swabs were taken from nasal, perinasal and 
lesional skin. These were referred for bacteriological studies. Skin scrapings were carried 
out for those patients with clinical features suggestive of scabies in search of scabies 
mites/ova or faecal pellets. Stool samples were examined for parasitic organisms, ova 
and/or cysts. 
Diagnosis for HTLV-I infection was determined according to the recommended stepwise 
procedure for the diagnosis of HTLV-I or II, i.e.screening for antibodies to HTLV-I was 
done using a particle agglutination test (Serodia ATLA, Fuji Rebio, Tokyo) as has been 
discussed in section 1.9. Positive sera were confirmed using the most widely used 
immunoblot assay, WB (HTLV Blot 2,4 Genelabs Diagnostics, Singapore). This test was 
used also in order to distinguish HTLV-I from HTLV-II. 
HIV-I positive sera were identified on all HTLV-I seropositive patients using Vironostika 
HIV-1 IMPVD Microelisa system (Biomerieux, Durham, NC). HIV-I viral loads using 
Nuclisens EasyQ HIV-I system (Biomerieux) were determined. CD4 and CD8 
lymphocyte subsets counts were calculated and the CD4/CD8 ratio was determined. A 
chest radiograph was done on all patients in search of chest related HTLV-I complication 
such as lymphocytic interstitial pneumonia. 
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2.3.3 Histological Investigations 
4mm punch biopsy skin specimens were taken from lesional skin on all those enrolled 
patients who gave consent for histological analysis. One dermatopathologist was 
responsible for the histological analysis. This pathologist was blinded as to the HIV status 
of the patients. 
Tissue specimens for histological examination were examined by light microscopy. 
Biopsies were fixed in buffered formalin and processes routinely for paraffin-wax 
embedding. Up to 15 serial histological sections were obtained from each biopsy 
specimen. 
2.3.4 PCR and Sequencing 
DNA was extracted from the peripheral blood morphonuclear cells DNA using QiaAmp 
Blood kit (Quiagen). Amplification of HTLV LTR region was performed as two 
overlapping fragments, an LTR-gag product of 473 bp and a tax-LTR product of 458 bp. 
Nested hot-start PCR and AmpliTaq Gold were used with cycling conducted on a Perkin 
Elmer 9700 thermal cycler under standard reaction conditions. Following separation on 
1% agarose gels, the PCR products were purified using a Qiaquick Gel Extraction kit 
(Quiagen) and subjected to cycle sequencing on an Applied Biosystems 3100 capillary 
sequencer. Edited sequences were aligned and analysed using a variety of different 
phylogenetic software programs (Maximum Likelihood, Neighbour Joining and PAUP 





Among the patients who presented at King Edward VIII outpatients department during 
the period of January 2003 and December 2005, 60 patients had clinical features 
suspected to be due to HAID. Of these thirty three (33) met the diagnostic criteria for 
HTLV-I associated infective dermatitis based on the following: HTLV-I seropositivity, 
onset of disease in early childhood, eczema with crusting of the scalp, external ear and 
retro-auricular area, relapsing and remitting clinical course during withdrawal and 
resumption of therapy respectively. Evidence consistent with minor criteria included a 
generalized fine papular rash, generalized lymphadenopathy, anaemia, raised erythrocyte 
sedimentation rate, raised CD4 count, CD8 count and CD4/8 ratio. 
3.1 Demography 
3.1.1 Age 
The mean age of patients with HAID was 17 years (SD 12.3) range (8 months- 46 years). 
One third (30.3%) of the patients fell between the ages 6 and 10 years, represented in 
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Figure 4: A histogram of the ase distribution in the cohort, age on the x axis and 
number of individuals on the y axis. 
3.1.2 Gender 
In the sample, 24 (72.7%) were female while 9 (22.27%) male, hence a female to male 
ratio of 2.6:1. In the age group < 12yrs, the female to male ratio was 1:1. In the over 12 
year group, 93.7% were females and only 6.7% were males, (Figure 5). 
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Age group 
childhood (<=12 years) 
adulthood (>12 years) 
Male Female 
Sex-patient 
Figure 5: Gender distribution between adults and children in patients with HAID 
3.1.3 Racial distribution 
All 33 (100%) of patients were of African origin. 
3.2 Study patients 
Of the 60 patients screened, 33 were confirmed HTLV-I associated infective dermatitis 
cases. A total of 27 patients were excluded from this study either because their HTLV-I 
serology was negative (n=22) or because their HTLV-I results could not be retrieved 
(n=4), while one (n=l) patient was HTLV-I positive but did not have other features of 
HAID. Refusal rate was nil. 
The 33 patients who fulfilled the clinical criteria had eczema in the following sites: 
exudative eczema on the scalp, neck and groin, a generalized papular rash and nasal 
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discharge and/or crusting of the anterior nares. An example of some of these features is 
shown in (Figures 6a and 6b). 
Figure 6a and 6b: A typical exudative eczema with nasal crusting. 
3.3 Dermatological examination 
The scalp was the commonest site of involvement, with 77.4% of all patients affected. 
This site was closely followed by ear involvement, with both the external ear and 
retroauricular areas involved, making up about 71%. The axillae were affected in 65% of 
patients (Figure 7). Paranasal involvement 58%, groin 55%, eyelid 52% and neck 39%. 
These skin lesions were erythematous, scaly and exudative with adherent yellowish 
crusts. Retroauricular fissures were also seen. Blepharoconjuctivitis was observed in 3 
(8.26%) of patients. A disseminated follicular papular eruption was found in 16 patients 
(23.5%), see (Figure 8). Lymphadenopathy was present in 18 (54.5%) patients. Chronic 
nasal discharge was observed in 16 (48.4%) patients, whereas crusting of the anterior 
nares was found in 13(39.3%). The remaining four patients (12.1%) exhibited neither 
chronic nasal discharge nor crusting of the anterior nares. Figure 9 graphically illustrates 
the frequent sites of skin involvement in our cohort with HAID. 
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Figure 7: Picture of patient 
demonstrating flexural involvement 
Figure 8: A seneralised papular 
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Figure 9: Anatomical sites involved in the HAID patients 
3.4 Complications 
A total of 11(33.3%) individuals in our cohort had complications associated with HAID. 
These were corneal opacities in 3 (8.26 %) patients {Figures 10a and 10b). Scabies was 
confirmed in 6 (18.1%) patients, while 2 (6%) patients had HAM / TSP. None of the 
patients had evidence of lymphocytic interstitial pneumonitis on chest radiograph. 
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10a) 10b) 
Figures 10a and 10b: Pictures demonstrating corneal opacities affectinz some patients 
with HMD 
3.5 Microscopy results 
3.5.1 Skin swabs 
As skins swabs were taken from more than 1 site in some patients, a total of 41 
specimens were collected. A single swab was taken from the perinasal skin, 18 swabs 
from anterior nares while 22 were taken from lesional skin. The single swab taken from 
perinasal skin revealed colonisation with Streptococcus pneumoniae. From the nasal skin 
swabs, results of the 18 swabs taken revealed that 14 (77.7%) of those were colonised by 
S. aureus. Streptococcal species were isolated in only 2 (11.1%) specimens taken from 
this site. Multiplicity of organisms was also found in 2 (11.1%) specimens. Findings from 
the swabs taken from lesional skin showed that S. aureus was present in 20 (90.9%) 
specimens while 15 (68.1%) of which also had Streptococcus species. Multiplicity of 
organisms was found in 1(4.5%) swab. These findings are summarised in Figure 11. The 
streptococcal species, isolated from the different regions were a combination of:J3-
haemolytic streptococcus (BHS), groups A, B, C and G, together with streptococcus 
pyogenes. The most common of these was BHS group G, which was found in 5/15 
(33.3%) swabs taken from the lesional skin. 
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Figure 11: A histogram showing the distribution of bacteriology results 
3.5.2 Stool sample results 
Stool samples were collected in 12 of the 33 patients and neither parasites nor ova were 
isolated from any of these specimens. 
3.6 Bloods Results 
3.6.1 Haematology 
A complete blood count could be retrieved in 25 of the 33 patients. Haemoglobin levels 
ranged from 8.0 to 14 g/dl. They had a mean Hb of 11.5g/dl. This was indicative of a 
mild anaemia which was defined as haemoglobin < 12 g/dl. The mean white cell count, 
differential counts and the platelet counts were within the normal limits, Table 6. 
Table 6: Summary of the blood count results 
Normal 









White cell count 
4.0-11.0 x 10A9/1 
10.1 x 10A9/1 
5.3 x 10A9/1 
17.4 x 10A9/1 
Platelet count 
150-450x 10A9/1 
405 x 10A9/1 
116 x 10A9/1 
607 x 10A9/1 
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3.6.2 Erythrocyte Sedimentation Rate (ESR) 
ESR results were available in 14 of the 33 patients. Of these, the mean was 53 mm/hr 
(range 10-130 mm/hr) and 12 (85.7%) patients had elevated (ESR > 15mm/hr) levels. 
3.6.3 HIV/HTLV-I co-infection 
All 33 (100%) patients with features of HAID were seropositive for HTLV-I serology. 
HIV results were retrieved in 30 of the 33 patients tested for this. Of these 9 (30%) were 
HIV positive, 21 (70 %) were HIV negative. Of the 9 HIV positive patients 8 were adults 
(age range 15- 41 years) and 1 was a child aged 8 months. Eighty-eight percent (88%) of 
the HIV positive patients were female. The mean viral load in this group was 52 000 
copies/ml. 
3.6.4 Immunology 
IgG levels were high in 16 (48.4%) of the patients evaluated. IgA was high in 8 (24.2%) 
of patients while IgM was found to be elevated in 2 (6%) of patients. The mean levels are 
depicted in Table 7. Levels for the IgD and IgE could not be determined due to the non-
availability of reagents in our laboratory, 
Table 7: Immunologic parameters among patients with HAID 
Variable (normal range) 
IgA (0.68 - 3.78 g/1) 
IgG (6.94- 16.18 g/1) 






Table 8: Results of serum electrophoresis inpatients with HAW 
Variable (normal range) 
Albumin (32-50 g/1) 
Alpha 1 globulin (1.72 - 3.30g/l) 
Alpha 2 globulin (4.2 - 8.7 g/1) 
Beta globulin (5.2-10.5 g/1) 







Tafo/e S include the results of the serum electrophoresis in all the enrolled patients, this is 
further illustrated in {Figure 12) below. 
[31] 
1 0 1 
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0 
Albumin Alpha 1 globulin Alpha 2 globulin Beta globulin Gamma globulin 
Figure 12: Schematic diagram of Protein Electrophoresis Result 
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3.6.5 CD4/ CD8 (entire group) 
CD4 counts were tested in 18 of the 33 patients. Their mean CD4 count levels was 1730 
cells/u.1 (range 114 - 3134 cells/ul) with a mean CD8 count of 1299 cells/u.1 (range 436 -
3433 cells /u.1). The CD4:CD8 ratio of the group was therefore 1.33. CD4 and CD8 
counts were checked for in 6 of the 9 patients co-infected with HIV. In this group CD4 
count levels were 1505 cells/ul, a CD8 level of 1704 cells/ul and therefore a ratio of 1:15. 
These results are shown in Table 9. 
Table 9: CD4 and CD8 count analysis 
CD4 cells/ul CD8cells/uI CD4/CD8 ratio 
Normal 550-1955 250-1200 0SA 
HTLV-1 1730 1299 1.33 
(n=18) 
HTLV-1+HIV 1505 1704 1.15 
(n=6) 
3.7 Virology 
All 33 patients were HTLV-I positive (particle agglutination test, confirmed on Western 
Blot). Only 12 of the 33 were subtyped, the predominant strain was found to be the 
Cosmopolitan, Subtype la. 
3.8 Histopathology results 
Histopathological examination was performed on punch biopsies of 31 patients. These 
biopsies were of various lesions in different stages of evolution and included papules, 
patches, eczematous areas and macules. The average number of biopsies per patient was 
two. A wide spectrum of histopathological features ware present and the salient features 
that were assessed were as follows: 
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• superficial perivascular dermatitis (SD) 
• deep perivascular dermatitis (PVD) 
• superficial and deep perivascular dermatitis (S/D-PVD) 
• lichenoid inflammatory dermatitis (LID) 
• interface dermatitis (ID) 
• seborrrhoeic dermatitis features (seb derm) 
• leucocytoclastic vasculitis (LCV) 
• chronic folliculitis (CF) 
Strict definitions of the above terms were used when assessing the biopsies e.g. 
Superficial perivascular dermatitis when viewed at scanning magnification is one of the 
most common reaction patterns in inflammatory skin pathology , characterized by the 
presence of inflammatory cells around venules in the upper reticular dermis. The 
inflammation may be confined to a zone around the venules (perivascular only) and may 
also occupy the interstitium (perivacular and interstitial) where the inflammatory cells are 
scattered within the collagen bundles. If the inflammation involved the venules deep 
within the dermis then this was called deep perivascular dermatitis. 
When epidermis was involved by the inflammatory infiltrate in a manner that obscured 
the dermoepidermal junction then this pattern was called interface dermatitis and if the 
inflammation was continuous along the interface with associated vacuolar alteration then 
this was called a lichenoid inflammatory dermatitis. 
Seborrhoeic dermatitis was diagnosed when mounds of scale crust in the epidermis were 
demonstrated with occasional neutrophils. Additional features were intercellular oedema 
causing widening between keratinocytes beneath the epidermis (spongiotic dermatitis). A 
dermal superficial perivascular and interstitial dermatitis was also present in some of the 
specimens. 
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Exudation of neutrophils with fibrin around dermal venules with nuclear dust and 
extravasation of red cells was designated leucocytoclastic vasculitis. 
When lymphocytes were identified within the hair follicules especially infundibular 
epithelium, this was designated chronic folliculitis. 
Superficial and deep perivascular dermatitis (S/D-PVD) was a major histological feature 
in our cohort with HAID. It was found present a single feature in 12 (38%) of the 31 
cases (Figure 13). S/D-PVD was also noted associated with a lichenoid inflammatory 
dermatitis (LID) in 28% of cases (Figure 14). Chronic dermatitis characterised by SVD-
PVD with interface dermatitis (ID) was found in 14 (12.9%) of the specimens. ID is 
shown in Figure 15. Two (6.4%) of the skin specimens had features in keeping with 
seborrhoeic dermatitis (seb derm), (Figure 16a and 16b). Seb derm is one clinical 
condition that can be mistaken for HAID. 
S/D-PVD was found associated with chronic folliculitis (CF) (Figure 17), in one (3.2%) 
case. There single cases (3.2%) of LID, CF and CF together with LID, respectively. One 
patient (3.2%) showed features of leucocytoclastic vasculitis (LCV). The patients who 
were co-infected with HIV showed similar features dominated by S/D-PVD but in 
addition their histology sections were studded with eosinophils. 
Figure 13: Superficial and deep 
perivascular dermatitis (S/D-PVD) 
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Figure 74: SVD-PVD + Lichenoid 
inflammatory dermatitis (LID) 
| Figure 15: Interface Dermatitis (ID) 
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Fieure 16a: Seborrhoeic dermatitis: Skin demonstrating mounds of scale crust with 
occasional neutrophils. Beneath this there is pallor of keratinocytes. A dermal 
superficial perivascular and interstitial dermatitis is also seen. 
Fieure 16b: Skin demonstrating sponsiotic dermatitis in seborrhoeic dermatitis 
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Figure 17a: Chronic folliculitis (CF ): Skin demonstrating lymphocytes within follicular 
especially infundibular epithelium. 
Figure 17 b: A deey section demonstrating chronic folliculitis 
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The spectrum of the histological features that were found in this group of patients is 
summarized in a pie diagram below (Figurel8). 
Figure 18: Histological characteristics of HAID 
M S/D-PVD 
• S/D-PVD +LID 
• S/D-PVD +ID 
D S/D-PVD +CF 
1 L I D 
• CF 
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| Seb Derm 
• LCV 
3.9 Data for the family members 
First degree relatives of 9 patients were assessed. Of these, 5 were mother - child pairs, 2 
fathers, and 2 siblings. They were examined for features of HAID and tested for HTLV-I. 
Of the mother and child pairs, 4 mothers and their 4 children had both clinical lesions of 
HAID and were HTLV-I positive. One mother had no features for HAID but the HTLV-I 
test was not performed. Both the fathers enrolled had no features for HAID and were 
HTLV-I negative. The siblings who were assessed showed clinical features suggestive of 
HAID but testing for HTLV-I was not done (Table JO). 
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Approximately half of the patients recruited met the established criteria for diagnosis of 
HAID. This may be indicative of the low sensitivity of the current criteria which may not 
distinguish the entity of HAID from the other clinical simulators. 
Demography 
4.1.1 Age 
The mean age in our patients was 17 years (range 8 months - 45 years). The majority of 
these were between the ages 6 and 10 years. Studies from Jamaica, where most work on 
this entity has been done, have shown that the usual onset of HAID is between the ages 2 
and 3. Therefore our study findings of mainly patients between ages 6 and 10 years were 
not out of keeping with the expected time of presentation, since in this study, only the age 
of presentation could be determined but not the onset of disease. The youngest in our 
series was just 8 months old. Symptoms appeared earlier in this patient than has been 
reported in the literature. However, there are some reports of HAID in patients as young 6 
months of age.46 This 8 month old patient was also co-infected with HIV and it is not 
known if the presence of the additional virus may have contributed to the early 
manifestation of symptoms in this patient. 
4.1.2 Gender 
There was an equal predominance of males and females in the childhood group, M: F = 
1:1 Studies of HAID have been mainly done in children and they have shown an overall 
predominance of females. This was not the case in our series as it was only in the adult 
group that a female predominance was observed with a M:F ratio of 1:2.5. Studies have 
documented a more efficient male-to-female transmission of HTLV-I compared to 
female-to-male transmission. However, there has been mixed findings from prospective 
studies with one study showing a higher male-female transmission47 whereas two others 
showed no significant difference in the transmission between the genders. The prevailing 
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postulate is that the differing male to female ratios in the childhood and adulthood group 
is reflective of the two modes of transmission of HTLV-I, vertical in the childhood group 
and sexual in the adults. Hormonal factors are thought to play a role in female 
susceptibility.47 
4.1.3 Racial distribution 
All 33 (100%) participants were African in our cohort. This sample was drawn from a 
tertiary hospital in KZN which mainly serves the African community in KZN, partly 
explaining this bias. In other studies conducted in South Africa,l5 in the Ngwelezane 
district in rural KZN, HTLV-I was found to be prevalent, the majority of the population is 
Black-African in this region, hence the link with poor socioeconomic status, but other 
populations have not been tested. 
4.2 Dermatological Examination 
4.2.1 Distribution of lesions 
The morphology and distribution of lesions were similar to that described in other studies 
with characteristic extensive involvement of the scalp and retroauricular areas with 
exudative crusted, infected lesions more common. Eyelid margins, paranasal skin, neck 
and axillae were also involved. Crusts were also noted in the nostrils and fissures were 
found behind the ears. The above characteristic features were observed more in the 
childhood group while the older age group exhibited these features in a less severe form. 
This was in keeping with studies showing that the bacterial infection tend to diminish 
with increasing age as the patients' immunity matures.11 
4.2.2 Nasal crusting 
The cases studied fulfilled all the major criteria of LeGranade et al4. Almost half (48.4%) 
of our patients had chronic nasal discharge without crusting in the nostrils, while 40% 
had crusting in the nostrils. It was noted that those that had chronic nasal discharge did 
not have crusting whereas the patients that had crusting of the nares did not have chronic 
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nasal discharge. 12% in our cohort had neither features. This finding was also described 
by Suite and colleagues who reported no chronic nasal discharge in 15 patients with 
HAID.48 Our results are in agreement with deOliviera and colleagues, who argue that 
nasal crusting or rhinorrhoea should not be made obligatory for the diagnosis of HAID.11 
The criteria may require revision because of the discrepancy between studies regarding 
the mandatory feature of "nasal crusting and/ or chronic nasal discharge". Our patients 
fulfilled most of the criteria for HAID except for the 4 patients that did not have the nasal 
crusting and/or discharge but fulfilled all other criteria. Due to the presence of the other 
criteria in these patients, including some of the minor criteria, we still felt that these four 
patients did have HAID. 
4.3 Complications 
Complications have been reported to occur in 30-35% of patients with this entity. In our 
group of patients, scabies was the most common complication affecting about 8.1% of all 
patients. None of these patients with scabies had the crusted type which is in contrast 
with what has been reported in the literature. A robust immune system in our cohort may 
explain the lack of development of crusted scabies, known to be associated with 
immunosuppression. 
The literature provides no clear explanation for the development of parasitic infestations 
like scabies. Postulations are that patients with HAID may be immunosuppressed and 
therefore predisposed to opportunistic infections, such as scabies. This postulate is being 
further explored by the authors. 
4.3.1 HAM/TSP 
Of the cohort of 33, 2(5.7%) had HTLV-I associated myelopathy. The two patients with 
myelopathy were adults aged 27 and 47 years, respectively. Both these patients 
complained of lower limb weakness and difficulty in walking. This was subsequently 
confirmed on neurological examination. In a series of 23 patients with HAID in Brazil, 5 
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of the cases (21.7%) were found to have myelopathy.11 In another study of 20 patients 
with HAID, 6 (30%) were found to have HAM/TSP. Both of these studies indicate a 
higher frequency of HAM/TSP in patients with HAID compared to what was found in 
our series. The average age of diagnosis of HAM/TSP is about 40 years and is thought to 
be preceded by adult acquired infection. The exact time when our 2 patients acquired 
HTLVT infection could not be determined. In general, myelopathy occurs more 
commonly in the absence of HAID but in the presence of HTLV-I. Our 2 patients may 
have acquired the infection in adulthood since both were adults. Should that be the case, 
then the development of myelopathy in them would have followed the natural history of 
the disease. However, development of this type of myelopathy in patients occurring 
between 12 and 25 years following the diagnosis of HAID has also been reported. 
Childhood infection with HTLV-I and later development of HAM/TSP cannot be ruled in 
these 2 patients. 
4.4 Microbiology 
Studies have shown that culture from the anterior nares and lesional skin yield S. aureus 
and/ or S. haemolyticus. In our patients S. aureus was the predominant organism found in 
both lesional skin and the anterior nares. S. aureus was isolated in 90% of swabs taken 
from lesional skin and this organism present together with streptococcal species in 68% 
of swabs taken from the same site. No pathogens were isolated from stool and urine. 
Most studies have performed this particular investigation aiming to exclude Strongyloides 
stercoralis which has been proposed as a co-factor of ATLL. A number of case reports 
have documented that this pathogen may be associated with a short latency period to 
ATLL. Ascaris lumbricoides has been the most common organism identified 
microscopically in stool of children. It is a normal pathogen in children with or without 
HAID but even this common pathogen was not cultured in our series. 
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4.5 Blood results 
4.5.1 Haemoglobin concentration 
In the cases we report only a mild anaemia, with the mean Hb of 11.5 g/dl (11.5 -
13.5g/dl). The type of anaemia was not characterized in our study; hence we are unable to 
speculate on a cause. However, with chronic skin conditions a normocytic normochromic 
anaemia initially occurs and as the condition progresses, there may be an iron deficiency 
picture due to loss of iron from the skin, dietary factors and concomitant infections. In 
other studies the anaemia was of the iron deficiency type.4 
4.5.2 WCC 
The mean WCC in our patients was 10.1xlOA9/l. this was within the normal range. This 
is in contrast to other studies which have demonstrated high total white cell counts with 
lymphocytosis.4 One of the reasons that our patients did not have an elevated WCC may 
have been related to the low level of complications in our group. 
4.5.3 ESR 
The ESR in our series was raised and this can be explained by the chronic underlying 
dermatosis. However, the level was 53mm/hr indicates that ESR which is only marginally 
raised. Should the ESR levels have been raised much higher > 50 mm/hr one would have 
search for underlying complications such as ATLL. 
4.5.4 Immunoglobulins results 
In keeping with previous studies, which have shown that HAID patients have a 
significant increase in their total immunoglobulins,28 immunoglobulin levels were also 
elevated in our patients. The mean levels were 3.94g/l (IgA), 21.41g/l (IgG) and 1.62g/l 
(IgM). In view of the fact that IgD and IgE could not be determined in our setting, the 
significance of elevation of IgA, IgG and IgM levels could not be determined. 
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4.5.5 CD4/CD8 Levels 
Studies for circulating T lymphocytes showed higher levels of activated T lymphocytes, 
an absolute CD4 count of 1730 cells/u.1 for the entire group of patients with HAID an 
increased CD4/CD8 ratio of 1.33. 
However, when analysed separately the HIV / HTLV-I co-infected group of patients had 
a mean CD4 count level of 1505 cells/u.1 compared to the mean CD4 count of the entire 
group of 1730 cells/uL This was not statistically significant (p=0.41). Previous studies 
have also shown a high CD4 count in patients who are HIV/HTLV-I co-infected. This 
can be interpreted as a reactional lymphocytosis and provides no benefit to the affected 
patients.41 CD4-count is therefore an unreliable parameter in HIV/HTLV-I co-infection. 
HIV viral load is the remains the only reliable parameter to be used to assess HIV stage in 
cases of HIV/HTLV-I co-infection. Studies have postulated that the elevation in the total 
lymphocyte count together with increased number of activated T cells and an increased 
CD4 / CD8 ratio is evidence of an altered immune function that seem to prevail in 
patients with HAID.37 
4.5.6 HIV/HTLV-I co-infection 
A total of 9 (30%) of the patients were co-infected with HIV. Of these, 8 were adults and 
1 was a child. The mean age in the adult group was 29.6 years and the age of the child 
was 8 months old. However, this child did not have PCR to exclude the presence of 
maternal antibodies to HIV. The fact that the majority of patients in this group came from 
the adults whereas the childhood group was predominantly HIV negative may represent 
co-incidental HIV co-infection in a group already at risk for HIV. It is possible that these 
patients already had HTLV-I infection since childhood and later acquired the HIV due to 
the high background prevalence of HIV in KwaZulu Natal. In South Africa, the HIV 
prevalence has reached its highest level with 29.5% of pregnant women being HIV 
positive in 2005. There is significant regional variation with the highest prevalence of 
39.1% recorded in KwaZulu-Natal, and the lowest in the Western Cape at 15.4%. 49 
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4.6 Genotyping 
A subgroup of the entire cohort was evaluated for genotyping. Of the 12 specimens which 
were sub-typed, all 12 were of the A subgroup of the Cosmopolitan (HTLV-I a) subtype. 
This finding was consistent with a previous study conducted in KZN, 26 where 5 patients 
were assessed. The Cosmopolitan, Subtype A is said to cause the majority of human 
infections studied to date.47 One hypothesis suggests that this worldwide distribution may 
have occurred over the past several hundred years via European voyages of discovery, the 
slave trade or other human migrations. 
4.7 Data for the family members 
Clusters of HAID were observed in the present study in at least 5 of the 9 families 
studied. The familial clustering suggests a genetic background and /or vertical spread. 
None of the family clusters were further analysed to exclude HAM/ TSP or ATLL. 
In a study of 23 patients with HAID with family members, which included 20 mothers 
and 41 siblings of the children who were participants, " 17 of the 20 mothers, and 6 of 
the 41 siblings tested were found to be seropositive for HTLV-I. Three of these family 
clusters were found to have HAM/TSP. In another study, one family cluster showed that 
both the mother and her 9 year old son had HAID and HAM/TSP, while her other 2 year 
old son was only seropositive for HTLV-I but did not have any HTLV-I associated 
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disease. This family also underwent genetic studies which revealed that they shared a 
similar haplotype DRB1*DQB1*. This is the same haplotype that has been described 
among Japanese patients with HAM/TSP. This haplotype is thought to have contributed 
to their risk for development of HAM/TSP. In these studies the enrolled patients were 
analysed further to ascertain if they had other HTLV-I associated illnesses whereas in our 
series, the families were only assessed to exclude HAID. 
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4.8 Histopathology 
Previous studies investigating the histology of HAID patients have not found any specific 
features. Features found were in keeping with chronic dermatitis characterized by 
interface dermatitis.8 However, in contrast to these findings described above, a wide 
spectrum of features was found in the current study. The major histological finding in this 
series was superficial and deep perivascular dermatitis SVD-PVD making up to 38% of 
all specimens analysed. The second was SVD-PVD together with a lichenoid 
inflammatory dermatitis (LID) making 28% of specimens analysed. Chronic dermatitis 
characterised by (SVD-PVD) together with interface dermatitis (ID) found in other 
studies was only found in only 12.9% of our cases. Other histological findings found in 
our series were individual cases of LCV, LID, CF. One section (3.2%) featured a 
combination of CF and LID. 3.2% of specimens showed a combination of SVD-PVD 
together with CF. 
However, in the HIV positive group, the main histological finding was also SVD-PVD 
with additional findings of an eosinophilic inflammatory infiltrate in the same specimens. 
Our finding of only 6.4% of patients with distinct features of seborrhoeic dermatitis 
histologically, supports the thinking that HAID is a unique entity and that it is not the 
same as seborrhoeic dermatitis. 
4.9 Study Limitations 
The first limitation of this study is that the dermatosis under question, HAID, is an 
uncommon condition. This has impacted on the small sample size, a total of only 33 
recruited over a period of 3 years, hence the results extrapolated may not be as 
representative as they would have been had the sample size been larger. This was purely 
a descriptive study and the results would have been more robust had there been a control 
arm of HTLV negative seborrhoeic dermatitis to compare with. The difficulty with 
recruiting this arm was due to the fact that most of the patients with seborrhoeic 
dermatitis who present to outpatient clinics in the public sector are infected with HIV. 
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Patients who are HIV negative HTLV negative, in our opinion, have such a mild disease 
that they either do not present or are seen in the private sector. However, the current 
study on HAID has given birth to another on HIV associated seborrhoeic dermatitis and 
will attempt to characterise the clinico-pathological characteristics of this entity. 
Having all the study results would have been ideal but in view of the study being carried 
out in a public hospital setting, loss of data is one of the major problems we have to face. 
Specimens have to be sent to different laboratory facilities. Due to logistics and poor 
sample handling, many results are commonly lost. Every attempt was made to chase all 




The dearth of published data characterising the entity of HTLV-I associated infective 
dermatitis in Africa and in Southern Africa in particular, underlines the importance of the 
objectives of this study. Characterising HAID in our local population, KZN, South Africa 
and comparing it to those described elsewhere is crucial to our understanding of the 
condition and adds to the current body of knowledge available worldwide. It also 
heightens awareness of this condition, which is currently under reported and under 
diagnosed and yet has devastating complications. 
HAID is an under recognised condition for various reasons: ignorance of the entity, a 
very mild dermatitis which may go undiagnosed and its resemblance and hence confusion 
with seborrhoeic dermatitis. With KZN being the epicentre of HIV/AIDS in the country 
and with South Africa having the highest number of persons estimated to be living with 
HIV, seborrhoeic dermatitis is one of the commonest inflammatory dermatoses that 
affects HIV infected individuals in our population. Clinical sites of involvement viz. 
scalp, retroauricular, axillae and paranasal involvement are common to both. However, 
HTLV-I seropositive status, the papular truncal rash and absence of groin involvement 
are peculiar features of HAID. 
The importance of establishing the entity and increasing awareness of HAID lies in the 
fact that it is a marker of underlying HTLV-I infection. These patients can then be 
followed up more closely so that complications such as ATLL, TSP and corneal opacities 
can be diagnosed and treated timeously. First degree relatives can also be screened for the 
infection and if necessary followed up more closely. 
The entity of HAID which we have described is mainly a disease of Africans in KZN, 
South Africa. This is in keeping with publications form other parts of Africa and 
reinforces the tendency for infection to be associated with low socio-economic status. It 
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usually manifests in childhood and continues into adulthood, characterised by remissions 
and relapses. Clinically the significant pattern was that of an extensive exudative 
eczematous eruption involving the scalp and retroauricular area. Involvement of the 
eyelid margins, perinasal skin, neck and axillae were also significant. Chronic nasal 
discharge and/or nasal crusting were present in the majority of our cohort but were not 
found in all the confirmed HAID patients. The latter finding is in keeping with other 
studies and supports the idea of its removal as a major criterion for the diagnosis of 
HAID.The secondary infection by microbes is a constant feature and explains the 
remissions and relapses, prompt response to antibiotic therapy and relapses when 
antibiotics are withdrawn. 
Genotyping revealed that the strain of HTLV-I infection affecting our cohort of patients 
in KZN, South Africa is the Cosmopolitan, Subtype A (HTLV-Ia). This is shared with the 
strain that is found in HAID patients in Brazil and supports the shared origin of this virus. 
The most common histological pattern was superficial and deep perivascular dermatitis 
with a small proportion having histological features of seborrhoeic dermatitis. Hence this 
feature is important in differentiating the entities of seborrhoeic dermatitis from HAID. 
The histological finding of superficial and deep perivascular dermatitis is non-specific 
and can be found in many other inflammatory and infectious conditions, however positive 
serology and clinical features of HAID will be necessary to make the diagnosis. 
The rate of co-infection with HIV was 30%, thought to be co-incidental due to the high 
HIV seroprevalence in adults in KZN, South Africa. However, there were no significant 
differences between the two groups except a more intense eosinophilic infiltrate on 
histological examination, a well described feature of HIV cutaneous pathology and HIV 
infection. 
In this study, we have described HAID as a distinct entity in African children in KZN, 
South Africa, characterised by exudative crusts of the scalp, retroauricular areas, axillae 
and perinasal skin confirmed by HTLV -I seropositivity. The subtype is Cosmopolitan, 
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Subtype A (HTLV-Ia) and the commonest pattern histologically is a superficial and deep 
perivascular infiltrate. Although the complication rate in our series was low, their 
occurrence is associated with high morbidity and mortality hence underlining the 
importance of HAID as a marker for infection with HTLV-I infection. 
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